Tango Therapeutics, Inc.
TNGX
Ранг среди акций
#4545
Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and... Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and development of innovative cancer treatments. Their primary therapeutic candidate, TNG908, is a synthetic lethal small molecule designed to inhibit protein arginine methyltransferase 5 (PRMT5). This compound is currently being advanced as a potential therapy for cancers characterized by methylthioadenosine phosphorylase (MTAP) deletions. Additionally, their pipeline includes an Ubiquitin-specific protease 1 (USP1) inhibitor targeting BRCA1 or BRCA2-mutant cancers, and a program known as 'Target 3' which addresses STK11-mutant cancers. Tango Therapeutics maintains a strategic alliance with Gilead Sciences, Inc., focused on the identification, advancement, and commercialization of a diverse array of cancer therapies. Established in 2017, the company's operations are headquartered in Cambridge, Massachusetts.
Цена акции
$27.18
Последняя синхронизация: 2026-07-31
Рыночная капитализация
$3.38B
Изменение (1 день)
-1.41%
Изменение (1 год)
202.34%
Страна
US
Торговля Tango Therapeutics, Inc. (TNGX)
Категория
Healthcare
Количество находящихся в обращении акций Tango Therapeutics, Inc. (TNGX)
Количество акций в обращении на June 2026: 149.88M
Согласно последним финансовым отчетам и цене акций Tango Therapeutics, Inc., текущее количество акций в обращении составляет 149.88M. На конец December 2023 у компании было 94.57M акций в обращении. Количество акций в обращении обычно зависит от сплитов и обратного выкупа акций.
История количества акций в обращении Tango Therapeutics, Inc. (TNGX) с 2019 по 2026
Акции в обращении на конец каждого года
| Год | Акции в обращении | Изменить |
|---|---|---|
| 2026 (TTM) | 149.88M | 37.22% |
| 2024 | 109.23M | 15.50% |
| 2023 | 94.57M | 7.69% |
| 2022 | 87.82M | 41.40% |
| 2021 | 62.11M | -29.00% |
| 2020 | 87.47M | 0.00% |
| 2019 | 87.47M | 0.00% |
Акции в обращении у аналогичных компаний или конкурентов
| Компания | Акции в обращении | Разница | Страна |
|---|---|---|---|
| 253.90M | 69.41% |
US
|
|
| 396.00M | 164.22% |
US
|
|
| 478.91M | 219.54% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | -58.51% |
NL
|
